Actively Recruiting

Age: 19Years +
All Genders
ID07057648

Shape-sensing Robotic-assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules A Prospective Cohort Study in Korea

Led by Ulsan University Hospital · Updated on 2026-02-13

100

Participants Needed

1

Research Sites

21 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating a new robotic technology called shape-sensing robotic-assisted bronchoscopy (ssRAB) to take tissue samples from peripheral lung nodules, which are small spots in the lungs that can sometimes be cancerous. Current methods for sampling these nodules are successful about 70% of the time, and this study aims to see if the ssRAB technology can improve accuracy and safety in diagnosing lung nodules in Korean patients. The ssRAB procedure uses the ION endoluminal system, which has fiber optic sensors to guide a thin catheter precisely to lung nodules for tissue sampling. Before the procedure, patients have a detailed chest CT scan for 3D planning. During the procedure, performed under sedation or general anesthesia, the robot assists navigation, and tissue is collected using biopsy needles, forceps, brushes, or cryobiopsy tools. Additional tools like radial endobronchial ultrasound and fluoroscopy may confirm positioning. Participants are monitored immediately after for complications and followed for 6 months to confirm diagnoses. Participants will undergo the robotic procedure once and be observed for any immediate complications with chest imaging and clinical checks for 24 hours post-procedure. They will then have follow-up visits for 6 months to verify diagnosis accuracy, using additional imaging or procedures if needed. Researchers will measure how often the procedure provides a definitive diagnosis, navigation success, tissue sample quality, and safety outcomes. The study includes 100 adults requiring lung nodule diagnosis and lasting approximately 6 months after the procedure for each participant.

CONDITIONS

Brief Title

Shape-Sensing Robotic-Assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules in Korea

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 19 years or older
  • Solid or part-solid peripheral pulmonary nodules confirmed on chest CT
  • Patients requiring histological diagnosis as determined by their doctor
  • Eligible for bronchoscopy procedure
  • Able to provide written informed consent
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2 or equivalent function allowing sedation or general anesthesia
Not Eligible

You will not qualify if you...

  • Pure ground glass opacity nodules
  • Bleeding tendency such as platelet count below 50,000/µL or INR above 1.5
  • Severe heart or lung problems preventing sedation or anesthesia
  • Pregnant or breastfeeding women
  • Life expectancy less than 6 months
  • Unable or unwilling to give informed consent
  • Absolute contraindication to bronchoscopy including severe low oxygen, severe pulmonary hypertension, recent heart attack (within 6 weeks), unstable angina, or serious heart rhythm problems
  • Participation in another clinical trial that could interfere with this study procedures or outcomes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit (in-person)

Implementation

Duration - Day 0

Participants undergo shape-sensing robotic-assisted bronchoscopy (ssRAB), a diagnostic procedure using a robotic system to navigate and obtain tissue samples from peripheral lung nodules under sedation or anesthesia. Pre-procedure planning includes CT imaging for 3D navigation. The procedure involves airway assessment, catheter navigation, tissue sampling, and optional ultrasound and fluoroscopic guidance.

1 procedure visit (in-person)

Follow-up

Duration - 6 months

Participants are monitored for procedure-related complications for 24 hours post-procedure through clinical observation and chest imaging. Additional follow-up occurs for up to 6 months to confirm the final diagnosis using imaging or further procedures if needed.

Follow-up visits as needed over 6 months

Trial Site Locations

Total: 1 location

1

Ulsan University Hospital

Ulsan, South Korea, 44033

Actively Recruiting

Loading map...

Research Team

G

Ganghee Chae, MD, PhD

T

Taehoon Lee, MD, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Randomized Controlled Multicenter Study on the Improvement...

Lung Cancers

Actively Recruiting

2 locations

Effectiveness of Acupuncture Combined With PD-1/PD-L1 Inhibi...

Lung Cancers

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Shape-sensing Robotic-assisted Bronchoscopy (SS-RAB) in Sampling Peripheral Pulmonary Nodules: A Prospective, Multicenter Clinical Feasibility Study in China.

Fangfang Xie, Quncheng Zhang, Chuanyong Mu...

https://pubmed.ncbi.nlm.nih.gov/39115240

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Hyuna Sung, Jacques Ferlay, Rebecca L Siegel...

https://pubmed.ncbi.nlm.nih.gov/33538338

Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017.

Heber MacMahon, David P Naidich, Jin Mo Goo...

https://pubmed.ncbi.nlm.nih.gov/28240562

Sensitivity and Safety of Electromagnetic Navigation Bronchoscopy for Lung Cancer Diagnosis: Systematic Review and Meta-analysis.

Erik E Folch, Gonzalo Labarca, Daniel Ospina-Delgado...

https://pubmed.ncbi.nlm.nih.gov/32450240